Nephrology Medical News about Carcinoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cost-Effectiveness of Sorafenib for Second-Line Treatment of Advanced Renal Cell Carcinoma
Value in Health, 10/13/09

Hoyle M et al. – Sorafenib has been shown to be clinically effective compared to BSC, offering additional health benefits; however, with a cost per QALY in excess of £70,000, it may not be regarded as a cost–effective use of resources in some health–care settings.

<< Previous
Is stenting required before retrograde intrarenal surgery with...

Next >>
Different Doses of Oral Folic Acid for Homocysteine-Lowering...

Superficially invasive transitional cell carcinoma of the bladder associated with distant cutaneous metastases
Journal of Cutaneous Pathology, 11/18/09 Relevance Score: 91%

Invasive papillary carcinoma of the male breast: Report of a rare case and review of the literature
Journal of Cancer Research and Therapeutics, 10/28/09 Relevance Score: 91%

Large-cell neuroendocrine carcinoma of the ampulla of Vater
Medical Oncology, 11/19/09 Relevance Score: 90%

Spread of Squamous Cell Carcinoma From the Thumb to the Small Finger via the Flexor Tendon Sheaths
The Journal of Hand Surgery, 11/16/09 Relevance Score: 90%

Local Biosynthesis of Estrogen in Human Endometrial Carcinoma through Tumor-Stromal Cell Interactions
Clinical Cancer Research, 10/06/09 Relevance Score: 90%